Literature DB >> 1754507

Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuro-endocrine carcinomas.

F Martinez-Madrigal1, J Bosq, C Micheau, P Nivet, B Luboinski.   

Abstract

Sixteen cases of paragangliomas of the head and neck including 8 of the vagal body, 3 of the carotid body, 2 jugulotympanic, 2 vagal or jugulotympanic and 1 of the larynx were analysed. Clinically, 13 tumors were benign, 2 showed local aggressivity and 1 showed metastases. All tumors were tested with antisera directed against neuron-specific enolase (NSE), chromogranin A (CGA), S-100 protein, neurofilaments (NF), glial fibrillary acid protein (GFAP) and cytokeratin (CK). Immunohistochemical results were compared with those of 5 cases of neuroendocrine carcinoma (NC) (1 of the oral vestibule, 1 of the larynx, 1 Merkel-cell tumor of the skin and 2 medullary thyroid carcinomas). Immunoreactivity for NSE and/or CGA was always positive in all paragangliomas and NC. S-100 protein was positive in sustenticular cells in all cases of paragangliomas and focally in two cases of NC. NF and GFAP were focally positive in 3 and 2 paragangliomas respectively; and in 1 NC. CK was constantly negative in all cases of paraganglioma and constantly positive in all cases of NC. Antibody anti-CK is the single most useful immunomarker for differential diagnosis between paraganglioma, frequently benign neoplasms and NC commonly aggressive in the head and neck. These findings are consistent with the current concepts of the neuroendocrine system.

Entities:  

Mesh:

Year:  1991        PMID: 1754507     DOI: 10.1016/S0344-0338(11)80577-7

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Studies for estimating the biologic behavior and prognosis of paragangliomas in the head and neck.

Authors:  H J Welkoborsky; Y Xiao; W J Mann; R G Amedee; H P Dienes; B Volk
Journal:  Skull Base Surg       Date:  1995

2.  Prognostic Factors Including Proliferation Markers Ki-67, bax, and bcl-2 in Temporal Bone Paraganglioma.

Authors:  M Gjuric; U Völker; A Katalinic; S R Wolf
Journal:  Skull Base Surg       Date:  1997

Review 3.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 4.  An extremely large solitary primary paraganglioma of the lung: report of a case.

Authors:  T Saeki; T Akiba; K Joh; K Inoue; N Doi; M Kanai; H Takeyama; T Takemura; E Ogoshi; S Ushigome; Y Yamazaki
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Melanotic paraganglioma of the posterior mediastinum.

Authors:  W J Hofmann; W Wöckel; O Thetter; H F Otto
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Transventricular paraganglioma of the larynx.

Authors:  S Gupta; K A Pathak; Vikram Sanghvi
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-12       Impact factor: 2.503

Review 7.  Paraganglioma of the nasal cavity: a case report.

Authors:  Sheyda Ketabchi; Daniela Massi; Roberto Santoro; Alessandro Franchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-01-21       Impact factor: 2.503

8.  Laryngeal paraganglioma: a rare clinical entity managed by supraselective embolization and lateral pharygotomy.

Authors:  Sudhir M Naik; Ashok M Shenoy; Purshottam Chavan; Akkamahadevi Patil; Sumit Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-10-06

9.  Unusual location of a cervical paraganglioma between the thyroid gland and the common carotid artery: case report.

Authors:  Fábio Roberto Pinto; Fábio de Aquino Capelli; Sueli Aparecida Maeda; Emílio Marcelo Pereira; Marcela Benetti Scarpa; Lenine Garcia Brandão
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.